Dr. Wulff-Burchfield is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2650 Shawnee Mission Pkwy
Fairway, KS 66205Phone+1 913-558-7750
Education & Training
- Vanderbilt University Medical CenterFellowship, Hospice and Palliative Medicine, 2016 - 2017
- Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2010 - 2013
- Duke University School of MedicineClass of 2010
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- MO State Medical License 2021 - 2026
- KS State Medical License 2017 - 2025
- TN State Medical License 2013 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Increasing Life Expectancy in Patients with Genitourinary Malignancies: Impact of Treatment Burden on Disease Management and Quality of Life.Marie-Pier St-Laurent, Bernard Bochner, James Catto, Benjamin J Davies, Christian Daniel Fankhauser
European Urology. 2024-12-19 - The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study.Cecilia A Castellano, Tianyi Sun, Deepak Ravindranathan, Clara Hwang, Nino Balanchivadze
Cancer. 2024-06-15 - Predictors of high-intensity care at the end of life among older adults with solid tumors: A population-based study.Courtney E Baird, Elizabeth Wulff-Burchfield, Pamela C Egan, Lee A Hugar, Ami Vyas
Journal of Geriatric Oncology. 2024-06-01
Press Mentions
- Acer Therapeutics Announces Initiation of Two Investigator-Sponsored Trials of ACER-801 (Osanetant) in Men with Adenocarcinoma of the ProstateJanuary 5th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: